Skip to main content
. Author manuscript; available in PMC: 2015 Mar 9.
Published in final edited form as: J Biol Rhythms. 2014 Sep 24;29(5):355–369. doi: 10.1177/0748730414549767

Table 3.

PER2::LUC bioluminescence parameters of WT and VIP−/− ex vivo explants.

WT VIP−/−
SCN
Period (hr) 25.84 ± 0.54 25.62 ± 0.60
Phase (first calculated peak) 14.38 ± 0.56 13.24 ± 1.47
Amplitude 154.10 ± 13.82 87.40 ± 19.57*
Damping Rate −0.61 ± 0.05 −0.42 ± 0.04**
R2 0.972 ± 0.015 0.968 ± 0.006

Pituitary
Period (hr) 23.54 ± 0.23 23.98 ± 0.68
Phase (first calculated peak) 16.96 ± 0.27 14.86 ± 0.66*
Amplitude 414.01 ± 60.65 138.67 ± 19.95**
Damping Rate −0.45 ± 0.03 −0.59 ± 0.05*
R2 0.992 ± 0.002 0.967 ± 0.009*

Liver
Period (hr) 25.73 ± 1.24 25.32 ± 0.62
Phase (first calculated peak) 18.12 ± 0.33 13.47 ± 0.63***
Amplitude 27.02 ± 10.40 102.54 ± 20.25**
Damping Rate −0.40 ± 0.04 −0.38 ± 0.09
R2 0.824 ± 0.037 0.797 ± 0.087

Heart
Period (hr) 24.90 ± 0.51 24.45 ± 0.41
Phase (first calculated peak) 19.81 ± 0.91 14.91 ± 0.52***
Amplitude 50.62 ± 11.68 38.52 ± 8.53
Damping Rate −0.53 ± 0.03 −0.42 ± 0.04
R2 0.985 ± 0.005 0.943 ± 0.014

Adrenal Glands
Period (hr) 24.40 ± 0.53 23.70 ± 0.90
Phase (first calculated peak) 13.47 ± 1.43 11.94 ± 1.55
Amplitude 24.31 ± 3.63 26.84 ± 4.41
Damping Rate −0.57 ± 0.05 −0.58 ± 0.05
R2 0.678 ± 0.069 0.692 ± 0.028

Ovary
Period (hr) 22.93 ± 0.53 24.25 ± 0.55
Phase (first calculated peak) 12.09 ± 1.52 10.85 ± 0.90
Amplitude 170.71 ± 49.90 167.29 ± 65.56
Damping Rate −0.57 ± 0.08 −0.53 ± 0.04
R2 0.923 ± 0.043 0.899 ± 0.039

Uterus
Period (hr) 24.00 ± 0.40 24.05 ± 0.49
Phase (first calculated peak) 16.06 ± 1.32 11.39 ± 1.52*
Amplitude 218.35 ± 70.77 230.47 ± 53.74
Damping Rate −0.47 ± 0.15 −0.45 ± 0.06
R2 0.867 ± 0.053 0.815 ± 0.072

Values are reported as mean ± S.E.M. n = 7 for WT and n = 10 for VIP−/−. Significant differences determined by Student’s t-tests between WT and VIP−/− mice are indicated with

*

for P < 0.05

**

for P < 0.01

***

for P < 0.001.

HHS Vulnerability Disclosure